Hinchcliff EM - Search Results

1

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, Mannel R, Shahin MS, Cantuaria GH, Girda E, Mathews C, Kavecansky J, Leath CA 3rd, Gien LT, Hinchcliff EM, Lele SB, Landrum LM, Backes F, O'Cearbhaill RE, Al Baghdadi T, Hill EK, Thaker PH, John VS, Welch S, Fader AN, Powell MA, Aghajanian C. Eskander RN, et al. Among authors: hinchcliff em. N Engl J Med. 2023 Jun 8;388(23):2159-2170. doi: 10.1056/NEJMoa2302312. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972022 Free PMC article. Clinical Trial.

2

Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer.

Mahdi H, Gockley A, Esselen K, Marquard J, Nutter B, Yang B, Hinchcliff E, Horowitz N, Rose PG. Mahdi H, et al. Gynecol Oncol. 2015 Dec;139(3):407-12. doi: 10.1016/j.ygyno.2015.07.101. Epub 2015 Jul 23. Gynecol Oncol. 2015. PMID: 26210778

3

Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer.

Hinchcliff E, Melamed A, Bregar A, Diver E, Clemmer J, Del Carmen M, Schorge JO, Alejandro Rauh-Hain J. Hinchcliff E, et al. Gynecol Oncol. 2018 Jan;148(1):168-173. doi: 10.1016/j.ygyno.2017.10.038. Epub 2017 Nov 8. Gynecol Oncol. 2018. PMID: 29128105

4

Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report.

Batman S, Rauh-Hain JA, Grinsfelder MO, Harrison R, Avila M, Cun H, How JA, Tandon N, Wang X, Hinchcliff E, Jazaeri AA, Schmeler KM. Batman S, et al. Case Rep Oncol. 2023 Apr 27;16(1):273-278. doi: 10.1159/000530154. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37123608 Free PMC article.

5

Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States.

Melamed A, Hinchcliff EM, Clemmer JT, Bregar AJ, Uppal S, Bostock I, Schorge JO, Del Carmen MG, Rauh-Hain JA. Melamed A, et al. Among authors: hinchcliff em. Gynecol Oncol. 2016 Nov;143(2):236-240. doi: 10.1016/j.ygyno.2016.09.002. Epub 2016 Sep 6. Gynecol Oncol. 2016. PMID: 27612977

6

Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.

Rauh-Hain JA, Hinchcliff EM, Oduyebo T, Worley MJ Jr, Andrade CA, Schorge JO, George S, Muto MG, del Carmen MG. Rauh-Hain JA, et al. Among authors: hinchcliff em. Int J Gynecol Cancer. 2014 Oct;24(8):1434-40. doi: 10.1097/IGC.0000000000000221. Int J Gynecol Cancer. 2014. PMID: 25248114

7

Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.

Rauh-Hain JA, Foley OW, Winograd D, Andrade C, Clark RM, Vargas RJ, Hinchcliff EM, Esselen KM, Horowitz NS, del Carmen MG. Rauh-Hain JA, et al. Among authors: hinchcliff em. Am J Obstet Gynecol. 2015 May;212(5):600.e1-8. doi: 10.1016/j.ajog.2014.12.013. Epub 2014 Dec 13. Am J Obstet Gynecol. 2015. PMID: 25514761

8

Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer.

Bercow AS, Nitecki R, Haber H, Gockley AA, Hinchcliff E, James K, Melamed A, Diver E, Kamdar MM, Feldman S, Growdon WB. Bercow AS, et al. Int J Gynecol Cancer. 2021 Jan;31(1):66-72. doi: 10.1136/ijgc-2020-001812. Epub 2020 Oct 12. Int J Gynecol Cancer. 2021. PMID: 33046575

9

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.

Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK, Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala T, Vining D, Ganeshan DM, Lu KH, Sun CC, Meyer LA, Jazaeri AA. Hinchcliff EM, et al. Cancer. 2024 Apr 1;130(7):1061-1071. doi: 10.1002/cncr.35126. Epub 2023 Nov 27. Cancer. 2024. PMID: 38009662 Clinical Trial.

10

Minimally Invasive Radical Hysterectomy for Cervical Cancer Is Associated With Reduced Morbidity and Similar Survival Outcomes Compared With Laparotomy.

Diver E, Hinchcliff E, Gockley A, Melamed A, Contrino L, Feldman S, Growdon W. Diver E, et al. J Minim Invasive Gynecol. 2017 Mar-Apr;24(3):402-406. doi: 10.1016/j.jmig.2016.12.005. Epub 2016 Dec 21. J Minim Invasive Gynecol. 2017. PMID: 28011096

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page